Author

Xiaohong Wang

MD anderson Cancer Center, Baylor College of Medicine (PhD), Tongji Medical College (MD) - Cited by 1,746 - Cancer immunotherapy - autoimmunity - immune cell signaling

Biography

Wang Xiaohong, an associate professor of the Institute of Microelectronics, Tsinghua University. She received the Ph.D. degree from Department of Precision Instruments and Mechanology on digital crystal resonant force sensors, Tsinghua University, in 1998. As a visiting scholar, she did the research on the electrode materials of micro solid oxide fuel cells in Professor Prinz Fritz’s group, in Stanford University, during Nov. 2005 to Oct. 2006. She also had a three-month visiting research experience in Hong Kong University of Science and Technology and UCLA, on micro fuel cells and nano – photodetector devices in 2001 and 2007, respectively.
Title
Cited by
Year
PDL1 Regulation by p53 via miR-34
MA Cortez, C Ivan, D Valdecanas, X Wang, HJ Peltier, Y Ye, L Araujo, ...Journal of the National Cancer Institute 108 (1), djv303, 2016201
541
2016
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
C Tang, X Wang, H SohCancer 2, 831-838, 2014201
295
2014
Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine
YF He, GM Zhang, XH Wang, H Zhang, Y Yuan, D Li, ZH FengThe Journal of Immunology 173 (8), 4919-4928, 2004200
224
2004
Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy
X Wang, JE Schoenhals, A Li, DR Valdecanas, H Ye, F Zang, C Tang, ...Cancer research 77 (4), 839-850, 2017201
197
2017
The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells
HC Chuang, JL Lan, DY Chen, CY Yang, YM Chen, JP Li, CY Huang, ...Nature immunology 12 (11), 1113-1118, 2011201
134
2011
MAP4K family kinases in immunity and inflammation
HC Chuang, X Wang, TH TanAdvances in immunology 129, 277-314, 2016201
122
2016
Regulation of PKC-θ function by phosphorylation in T cell receptor signaling
X Wang, HC Chuang, JP Li, TH TanFrontiers in immunology 3, 197, 2012201
79
2012
Indoleamine 2, 3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells
A Li, HB Barsoumian, JE Schoenhals, TR Cushman, MS Caetano, ...Cancer letters 431, -63, 2018201
54
2018
Down-regulation of B cell receptor signaling by hematopoietic progenitor kinase 1 (HPK1)-mediated phosphorylation and ubiquitination of activated B cell linker protein (BLNK)
X Wang, JP Li, HK Kuo, LL Chiu, GA Dement, JL Lan, DY Chen, CY Yang, ...Journal of Biological Chemistry 287 (14), 11037-11048, 2012201
46
2012
Attenuation of T cell receptor signaling by serine phosphorylation-mediated lysine 30 ubiquitination of SLP-76 protein
X Wang, JP Li, LL Chiu, JL Lan, DY Chen, J Boomer, TH TanJournal of Biological Chemistry 287 (41), 34091-34100, 2012201
43
2012
Soluble PD-1 can augment anti-tumor immunity induced by HSP70-peptide complex in tumor-bearing mice].
XH Wang, GM Zhang, YF He, H Zhang, ZH FengChinese journal of cellular and molecular immunology 20 (), 55, 2004200
6
2004
Eukaryotic expression and functional characterization of PD-1 extracellular domain
YF He, GM Zhang, XH Wang, H Zhang, Y Yuan, D Li, ZH FengSheng wu Gong Cheng xue bao= Chinese Journal of Biotechnology 20 (), 699-703, 2004200
5
2004

Referred From: https://scholar.google.com/citations?user=63XBC3YAAAAJ&hl=en

Cited by
Citations 1746
h-index 10
i10-index 10
Recommended Journals
Open Access Journals